tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CCCC Stock Latest News

C4 Therapeutics Outlines 2025 Milestones and Achievements
Company AnnouncementsC4 Therapeutics Outlines 2025 Milestones and Achievements
4d ago
8K
CCCC
C4 Therapeutics announces anticipated 2025 milestones
PremiumThe Fly
C4 Therapeutics announces anticipated 2025 milestones
4d ago
CCCC
C4 Therapeutics price target raised to $50 from $39 at Brookline
PremiumThe Fly
C4 Therapeutics price target raised to $50 from $39 at Brookline
12d ago
CCCC
C4 Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
PremiumThe Fly
C4 Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
1M ago
CCCC
C4 Therapeutics presents cemsidomide Phase 1 data at ASH
PremiumThe Fly
C4 Therapeutics presents cemsidomide Phase 1 data at ASH
1M ago
CCCC
C4 Therapeutics Appoints Steve Hoerter to Board
PremiumCompany AnnouncementsC4 Therapeutics Appoints Steve Hoerter to Board
2M ago
8K
CCCC
C4 Therapeutics appoints Hoerter to board of directors
Premium
The Fly
C4 Therapeutics appoints Hoerter to board of directors
2M ago
CCCC
C4 Therapeutics initiated with an Equal Weight at Stephens
Premium
The Fly
C4 Therapeutics initiated with an Equal Weight at Stephens
2M ago
CCCC
C4 Therapeutics announces first patient dosed in CFT8919 clinical trial
PremiumThe Fly
C4 Therapeutics announces first patient dosed in CFT8919 clinical trial
2M ago
CCCC
C4 Therapeutics Advances in Protein Degradation Therapy
PremiumCompany Announcements
C4 Therapeutics Advances in Protein Degradation Therapy
3M ago
CCCC
C4 Therapeutics files $400M mixed securities shelf
PremiumThe Fly
C4 Therapeutics files $400M mixed securities shelf
3M ago
CCCC
C4 Therapeutics files to sell 4.87M shares of common stock for holders
PremiumThe Fly
C4 Therapeutics files to sell 4.87M shares of common stock for holders
3M ago
CCCC
C4 Therapeutics reports Q3 EPS (35c), consensus (38c)
PremiumThe FlyC4 Therapeutics reports Q3 EPS (35c), consensus (38c)
3M ago
CCCC
C4 Therapeutics Appoints New Chief Scientific Officer
Premium
Company Announcements
C4 Therapeutics Appoints New Chief Scientific Officer
3M ago
8K
CCCC
C4 Therapeutics appoints Paige Mahaney, Ph.D., as Chief Scientific Officer
Premium
The Fly
C4 Therapeutics appoints Paige Mahaney, Ph.D., as Chief Scientific Officer
3M ago
CCCC
C4 Therapeutics announces next steps for CFT1946
PremiumThe Fly
C4 Therapeutics announces next steps for CFT1946
4M ago
CCCC
C4 Therapeutics presents monotherapy data from CFT1946 Phase 1 trial
PremiumThe Fly
C4 Therapeutics presents monotherapy data from CFT1946 Phase 1 trial
4M ago
CCCC
C4 Therapeutics announces delivery of second development candidate to Biogen
PremiumThe Fly
C4 Therapeutics announces delivery of second development candidate to Biogen
4M ago
BIIB
CCCC
C4 Therapeutics Announces Board Changes and Strategic Shift
PremiumCompany Announcements
C4 Therapeutics Announces Board Changes and Strategic Shift
5M ago
8K
CCCC
C4 Therapeutics appoints Stephen Fawell to board of directors
PremiumThe FlyC4 Therapeutics appoints Stephen Fawell to board of directors
5M ago
AZN
CCCC
C4 Therapeutics expects cash to provide runway into 2027
Premium
The Fly
C4 Therapeutics expects cash to provide runway into 2027
6M ago
CCCC
C4 Therapeutics reports Q2 EPS (26c) , consensus (37c)
Premium
The Fly
C4 Therapeutics reports Q2 EPS (26c) , consensus (37c)
6M ago
CCCC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >